Neogen Corporation Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Neogen Corporation (NEOG) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $2.09 billion as of 2026-05-31, per its 10-K filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-07-30
- 2026-05-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.09B.
- 2026-02-28: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.10B.
- 2025-11-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.10B; Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed $2.10B.
- 2025-08-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $2.12B; Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed $2.12B.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest as first filed |
|---|---|---|
| 2026-05-31 | $2.09B 10-K · filed 2026-07-30 | |
| 2026-02-28 | $2.10B 10-Q · filed 2026-04-09 | |
| 2025-11-30 | $2.10B 10-Q · filed 2026-04-09 | $2.10B 10-Q · filed 2026-01-08 |
| 2025-08-31 | $2.12B 10-Q · filed 2026-04-09 | $2.12B 10-Q · filed 2025-10-09 |
| 2025-05-31 | $2.07B 10-K · filed 2026-07-30 | $2.07B 10-K · filed 2025-07-30 |
| 2025-02-28 | $2.66B 10-Q · filed 2026-04-09 | $2.66B 10-Q · filed 2025-04-09 |
| 2024-11-30 | $2.67B 10-Q · filed 2026-04-09 | $2.67B 10-Q · filed 2025-01-15 |
| 2024-08-31 | $3.14B 10-Q · filed 2026-04-09 | $3.14B 10-Q · filed 2024-10-10 |
| 2024-05-31 | $3.14B 10-K · filed 2026-07-30 | $3.14B 10-K · filed 2024-07-30 |
| 2024-02-29 | $3.15B 10-Q · filed 2025-04-09 | |
| 2023-11-30 | $3.15B 10-Q · filed 2025-04-09 | |
| 2023-08-31 | $3.15B 10-Q · filed 2025-04-09 | |
| 2023-05-31 | $3.13B 10-K · filed 2026-07-30 | $3.13B 10-K · filed 2023-08-15 |
| 2023-02-28 | $3.13B 10-Q · filed 2024-04-09 | |
| 2022-11-30 | $3.11B 10-Q · filed 2024-04-09 | |
| 2022-08-31 | $883.80M 10-Q · filed 2024-04-09 | |
| 2022-05-31 | $887.37M 10-K · filed 2025-07-30 | |
| 2022-02-28 | $875.54M 10-Q · filed 2023-04-04 | |
| 2021-11-30 | $865.48M 10-Q · filed 2023-04-04 | |
| 2021-08-31 | $855.36M 10-Q · filed 2023-04-04 | |
| 2021-05-31 | $840.38M 10-K · filed 2024-07-30 | |
| 2021-02-28 | $807.68M 10-Q · filed 2022-04-01 | |
| 2020-11-30 | $777.39M 10-Q · filed 2022-04-01 | |
| 2020-08-31 | $751.55M 10-Q · filed 2022-04-01 | |
| 2020-05-31 | $725.18M 10-K · filed 2023-08-15 | |
| 2020-02-29 | $711.87M 10-Q · filed 2021-03-31 | |
| 2019-11-30 | $690.92M 10-Q · filed 2021-03-31 | |
| 2019-08-31 | $660.31M 10-Q · filed 2021-03-31 | |
| 2019-05-31 | $637.90M 10-K · filed 2022-07-27 | |
| 2019-02-28 | $619.92M 10-Q · filed 2020-04-03 | |
| 2018-11-30 | $602.07M 10-Q · filed 2020-04-03 | |
| 2018-08-31 | $581.63M 10-Q · filed 2020-04-03 | |
| 2018-05-31 | $560.17M 10-K · filed 2021-07-30 | |
| 2018-02-28 | $541.93M 10-Q · filed 2018-03-29 | |
| 2017-11-30 | $520.64M 10-Q · filed 2018-01-05 | |
| 2017-08-31 | $487.25M 10-Q · filed 2017-09-29 | |
| 2017-05-31 | $471.76M 10-K · filed 2020-07-30 | |
| 2017-02-28 | $451.66M 10-Q · filed 2017-03-31 | |
| 2016-11-30 | $434.77M 10-Q · filed 2016-12-29 | |
| 2016-08-31 | $417.22M 10-Q · filed 2016-09-30 | |
| 2016-05-31 | $404.16M 10-K · filed 2019-07-30 | $404.16M 10-K · filed 2016-07-29 |
| 2016-02-29 | $387.87M 10-Q · filed 2016-03-31 | |
| 2015-11-30 | $377.90M 10-Q · filed 2016-01-08 | |
| 2015-08-31 | $365.91M 10-Q · filed 2015-09-30 | |
| 2015-05-31 | $350.96M 10-K · filed 2018-07-27 | |
| 2015-02-28 | $336.71M 10-Q · filed 2015-04-01 | |
| 2014-11-30 | $326.78M 10-Q · filed 2014-12-30 | |
| 2014-08-31 | $318.87M 10-Q · filed 2014-09-30 | |
| 2014-05-31 | $306.30M 10-K · filed 2017-07-28 | |
| 2014-02-28 | $291.12M 10-Q · filed 2014-04-04 | |
| 2013-11-30 | $281.81M 10-Q · filed 2014-01-09 | |
| 2013-08-31 | $270.72M 10-Q · filed 2013-09-30 | |
| 2013-05-31 | $258.29M 10-K · filed 2016-07-29 | |
| 2013-02-28 | $245.70M 10-Q · filed 2013-03-28 | |
| 2012-11-30 | $237.71M 10-Q · filed 2012-12-28 | |
| 2012-08-31 | $229.22M 10-Q · filed 2012-09-28 | |
| 2012-05-31 | $219.05M 10-K · filed 2015-07-30 | |
| 2012-02-29 | $209.98M 10-Q · filed 2012-03-30 | |
| 2011-11-30 | $203.13M 10-Q · filed 2011-12-30 | |
| 2011-08-31 | $196.57M 10-Q · filed 2011-09-30 | |
| 2011-05-31 | $189.10M 10-K · filed 2014-07-30 | $188.98M 10-Q · filed 2011-09-30 |
| 2010-05-31 | $153.22M 10-K · filed 2013-07-30 | $153.05M 10-K · filed 2012-07-30 |
| 2009-05-31 | $128.68M 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |